good clinical laboratory practice (glp) standards and guidelines for good clinical laboratory practice standards
Dr.KiaraSimpson,United States,Researcher
Published Date:05-07-2017
Your Website URL(Optional)
Comment
Guidelines for Good Clinical Laboratory Practices (GCLP)
GOOD CLINICAL LABORATORY PRACTICES (GCLP)
1.0 INTRODUCTION
Laboratory services are an integral part of disease diagnosis, treatment, monitoring
response to treatment, disease surveillance programmes and clinical research. The
World Development Report 1993, regarded provision of Essential Health Technology
as an important ingredient of Essential Clinical Services. Use of diagnostic techniques
aid early diagnosis enabling appropriate and prompt intervention thereby reducing
overall disease burden and promoting health. All laboratories are not equipped with
facilities for carrying out complex investigations. The structure and function of a clinical
laboratory varies according to the level of health care facility. Peripheral laboratories
carry out simple tests like urine analysis and haemoglobin estimation whereas higher
centers are equipped with sophisticated technology and trained manpower to carry
out complex investigations. Establishing a network between peripheral and higher
laboratories allows collection of specimen at periphery and their storage and transport
for testing at higher centers and communicating report to the peripheral center efficiently
without actually having to transfer the patient. In the event of patient transfer, the higher
centers do not need to repeat investigations carried out at the peripheral health center,
thereby saving crucial time as well as cost and providing continuity in patient care.
Networking between laboratories is also essential in disease surveillance programmes
and outbreak investigations in order to obtain quick and reliable results.
The expert committee on Revamping of Public Health System identified the surveillance
and control of diseases as an important function of public health system. This formed
the conceptual framework of Integrated Disease Surveillance Programme (IDSP) which
was started in 2004 in a phased manner. The key components of IDSP are coordination
and decentralization of disease surveillance activities, improvement of laboratory
support and strengthening data quality. Inclusion of private laboratories to act as sentinel
sites and improve community participation are some other important features. The
Reproductive and Child Health - II programme of Government of India in 2005, indicated
the need for developing public-private partnership in health care including outsourcing
of health care, laboratory services and others. It outlines the need for accreditation of
service quality including protocols for quality assurance and certification. In India,
medical laboratories can volunteer for accreditation of one or more services offered
by them. The National Accreditation Board for Testing and Calibration Laboratories
(NABL) has been providing accreditation services to medical laboratories since 1998
and is currently following ISO 15189; 2007 standards.
In biomedical research too, achieving a set standard of quality produces credible
results and allows comparison between studies carried out at different institutes
nationally and internationally. This saves enormous time, money and resources and
prevents duplication of research work. The International Conference on Harmonization
(ICH) provided Good Clinical Practices (GCP) Guidelines which describe standards
INDIAN COUNCIL OF MEDICAL RESEARCH 1Guidelines for Good Clinical Laboratory Practices (GCLP)
to be followed by researchers while designing, conducting and reporting trials involving
human participants. Realizing the rapid pace, wide spectrum and potential for clinical
research in our country, the Indian Council of Medical Research (ICMR) launched the
Ethical Guidelines for Biomedical Research on Human Subjects in 2000 (revised in
2006) and Central Drugs Standard Control Organisation (CDSCO) released the Indian
Good Clinical Practices (GCP) guidelines in 2002 to guide biomedical research in the
country. To harmonize practices and generate mutually acceptable data for non-clinical
health and environmental safety studies the Organization for Economic Co-
operation and Development (OECD) evolved Good Laboratory Practice (GLP)
guidelines. India is a signatory to OECD and National GLP Compliance Monitoring
Authority established in the year 2002 by the Department of Science & Technology,
Government of India, provides GLP compliance certification to the test facilities involved
in conducting safety studies on chemicals (viz. industrial chemicals, pharmaceuticals,
veterinary drugs, pesticides, cosmetic products, food products, feed additives, etc).
To ensure reliability of data quality, WHO/TDR (Research and Training in Tropical
Diseases) has developed good practice guidelines for laboratories involved in clinical
trials. However, standards have not yet been developed in India for this purpose. The
proposed ICMR guidelines for Good Clinical Laboratory Practices (GCLP) aim
to elucidate step wise procedures which should be followed by laboratories to
strengthen the quality of test results. These guidelines should be adopted by all
ICMR laboratories engaged in research as well as patient care. ICMR carries
out research activities through its own institutes as well as through approved research
centers in the public and private health systems. It also provides financial support to
projects submitted by individual researchers and institutes. Adopting these guidelines
will lead to generation of uniformly acceptable and good quality laboratory data.
Subsequently, a checklist will be prepared to monitor these laboratories for
compliance with these guidelines.
2.0 SCOPE
Good Clinical Laboratory Practices should be used by all laboratories where tests are
done on biological specimens for diagnosis, patient care, disease control and research
such as:
• Microbiology & Serology
• Hematology & Blood Banking
• Molecular Biology and Molecular Pathology
• Clinical Pathology
• Clinical Biochemistry
• Immunology (Immunohematology and Immunobiochemistry)
• Histopathology/Pathology and Cytology
2 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
3.0 LEVELS OF LABORATORIES
In India, the laboratory services are integrated with the 3-tier public health system at
the primary, secondary and tertiary levels. Besides these, there are Reference
Laboratories, Research Laboratories and Specific Disease Reference Laboratories
to provide services for complex and special tests. The private sector provides laboratory
support at all levels of health care both in rural and urban areas. Each laboratory
should identify the scope, functions and the capacity of the services offered by it and
appropriate infrastructure with requisite biosafety measures should be planned.
Qualified and trained staff should be employed with periodic up-gradation of their skills.
3.1 Primary Level
Simple laboratory tests such as haemoglobin estimation and urine examination for
albumin and sugar are carried out at Primary Health Centers (PHCs) and Urban Health
Centers (UHCs) by laboratory technicians. Most PHCs and UHCs also have
microscopy facilities and trained technicians for examining blood smear for malarial
parasite and sputum for acid-fast bacilli (AFB) and a cold chain system. The Community
Health Centers (CHCs) receive referrals from PHCs and the laboratory technicians
are trained and equipped to handle additional laboratory investigations for the
management of medical and surgical emergencies and making etiological diagnosis
of RTIs/STIs. Facilities for screening of G6PD deficiency, sickle cell anaemia and
thalassemia are also available for vulnerable communities. Under IDSP, training will
be provided for diagnosis of typhoid using kits, detection of chlorination levels and
fecal contamination in water samples.
3.2 Secondary level
The district hospitals have facilities and manpower for carrying out pathology, clinical
pathology, biochemistry, serology, and microbiological investigations. They also carry
out tests of water quality and receive referrals from primary level facilities. The laboratory
staff includes pathologists, microbiologists, cytotechnicians, laboratory technicians,
blood bank technicians and laboratory attendants.
3.3 Tertiary level
The medical college hospitals and non-teaching large hospitals are equipped with
sophisticated diagnostic and investigative facilities to provide tertiary level health care.
These hospitals receive referrals from the primary as well as the secondary levels.
INDIAN COUNCIL OF MEDICAL RESEARCH 3Guidelines for Good Clinical Laboratory Practices (GCLP)
3.4 Reference Laboratories, Research Laboratories and Specific Disease
Reference Laboratories
The Reference Laboratories, Research Laboratories and Specific Disease Reference
Laboratories provide services in a specialized field or area of importance. These may
be located in a medical college, research institution or a private institution. They set
and should maintain high standards of quality in one or more particular area and
therefore receive referrals specific to that field. They also offer consultancy, standardize
diagnostic tests and carry out training pertaining to that specific area.
4.0 INFRASTRUCTURE
Infrastructure of laboratories should be planned according to the services provided by
the laboratory. The basic infrastructure facilities include:
• Reception room/area where requisition forms are received and reports
disbursed
• Specimen collection room/area, toilets, privacy for special purposes eg. semen
collection, facilities for disabled persons, toilet for staff
• Quality water supply for analytical purpose
• Uninterrupted power supply
• Analytical work area
• Specimen/Sample/slide storage facility including cold storage where applicable
• Record room/area
• Facility for cleaning of glassware, sterilization /disinfection
• Waste disposal facility including biomedical wastes
• Fire-safety equipment
• Ventilation, climate control and lighting arrangements
• Separate room/area for meetings/administrative work
• Separate facilities/area for staff for hand washing, eating and storing food,
drinks etc.
• Communication facility with referral centers
• Transport of specimen/samples to referral centers
• Additional infrastructure facilities may be added for special tasks as and when
needed.
5.0 PERSONNEL, TRAINING AND DEVELOPMENT
• Each laboratory should designate a Head of the laboratory who should be
overall in-charge of the daily functioning of the laboratory including
administration. A Quality Manager should be designated for monitoring and
maintaining of day-to-day quality management system.
4 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
• The qualifications and experience of the staff outlined in NABL document 112
(2007) should be followed unless specified by the health care providers.
• The strength of staff employed should be appropriate to the level of facility and
the workload.
• The roles and responsibilities of the staff should be clearly outlined. The staff
should also understand the nature of work assigned to them and must be
capable of performing the tasks independently beyond routine working hours if
the need arises.
• A programme for technical training and updating of skills on a regular basis
should be in place. The laboratory management should be committed for
providing continuing professional development and training opportunities to
staff. Action plan for improvement in the laboratory should be determined and
revised according to the feedback received from previous trainings and
experiences.
• Laboratory should organize or conduct periodic staff evaluation, preferably
once a year; frequency and method of evaluation should be decided by the
laboratory.
• The laboratory should maintain a personal file of all the technical and non-
technical staff employed. Personal file should contain all information on:
Ø Personal bio-data including educational qualification and experience
Ø Copy of degree/diploma and registration with state authority if applicable
Ø Copy of appointment letter
Ø Duly verified health information (physical fitness including color blindness,
immunizations received etc.) prepared at the time of employment and its
regular updates
Ø Performance appraisal
Ø Training certificates, awards/recognition received
Ø Disciplinary action if any taken by the management
Ø Reference letter from previous employer if applicable
6.0 EQUIPMENT
• Each laboratory should prepare an exhaustive list of equipment and
consumables required and available for general functioning of the laboratory
and specialized equipment for special tests.
• Laboratory equipment should be of adequate capacity to meet work load
requirement.
INDIAN COUNCIL OF MEDICAL RESEARCH 5Guidelines for Good Clinical Laboratory Practices (GCLP)
• Equipment should be suitably located in the laboratory so as to allow
accessibility and sequential utilization thus minimizing the need for frequent
movement of specimens or reagents.
• All equipment should be in good working condition at all times. Periodic
inspection, cleaning, maintenance of equipment should be done. An equipment
log book should be maintained for all major equipment. Laboratories should
maintain necessary instructions for operation and maintenance of equipment
in the form of Standard Operating Procedures (SOPs). A copy of SOP should
be readily available.
• Maintenance contracts including warranty cards, telephone numbers of staff
to be contacted in case of equipment malfunction should be kept safely. User
manual should be available readily for reference. The staff should be aware of
trouble shooting measures to be adopted for preventing equipment malfunction.
A format of the equipment log book provided in Annexure 1 can be used.
• New equipment should be calibrated and validated before routine use. AMR
(Analytical Measurement range) should be verified, manufacturer can be
consulted for verification and selection of range.
• Periodic performance check/calibration check for all equipment should be done
using reference standard/reference material. The frequency of performance
check should be based on the day-to-day performance of the equipment.
• Equipment performance should be verified from Internal Quality Control results
and External Quality Assessment results. Outlier parameter trend analysis
record should be maintained in respect of its effect on the equipment.
• All analytical equipment should be calibrated and calibration certificate provided
by equipment company. Non-analytical equipment such as pipette,
thermometer, weighing balance and centrifuge should be calibrated by
accredited calibration laboratory or done in-house with traceability to National
Physical Laboratory (NPL). For in-house calibration, laboratories should use :
Ø Calibrated tachometer - for centrifuge
Ø Calibrated digital temperature sensor - for checking temperature of
refrigerator, incubator etc.
Ø Calibrated glass thermometer- for temperature checking of oven, water
bath etc.
Ø Calibrated weights - for balance
6 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
Ø National Institute of Science and Technology (NIST) buffer - for pH meter.
Standard buffer solutions bought from reputed manufacturers with
certifiable traceability can be used as alternative.
• Equipment measuring pressure, temperature, humidity etc. should be checked
by using suitable reference standards.
7.0 REAGENTS AND MATERIALS
• Standard reagents of certified quality must be used for the purpose of analysis.
The batch number of reagents must be recorded. The quality of the reagent
viz. Analar grade, HPLC grade, etc. to be used for in-house procedures should
be defined in SOP
• The reagents, chemicals and consumables should be stored under appropriate
environmental conditions.
• Quality of newly purchased reagents should be validated against suitable
control/reference material prior to use. Validation data should be properly
documented. In-house prepared reagents should also be checked periodically
for stability and a record of the same should be maintained.
• Reagent label should contain name of reagent, concentration, date of
preparation/opening, date of expiry, storage conditions and warnings eg. 'do
not use if solution is turbid' where applicable. When individual bottles are small,
this information can be recorded in a goods received ledger.
• Microbiology laboratories should check activity/potency of each lot of antibiotic
sensitivity discs before using and at least weekly thereafter with reference
strains. Other microbiological consumables such as strips etc. used for
identification should be checked against reference strains. Laboratories testing
microbiology specimens should check the quality of media by using appropriate
reference strain and pH of the media.
• All batches of culture containers should be checked for sterility before issuing
to patients for collection of specimen.
• Water quality should be checked for its grade and presence of interference
elements. Reagent grade water according to IS1070 : 1992 of Bureau of Indian
Standards (BIS) should be used for testing.
INDIAN COUNCIL OF MEDICAL RESEARCH 7Guidelines for Good Clinical Laboratory Practices (GCLP)
8.0 SPECIMEN COLLECTION
• Specimen collection is the first phase of interaction between the patient and
the laboratory. Appropriate counselling should be done before specimen
collection and consent taken whenever needed. Attention should be paid to
patient's sensibilities during the entire process. Any error in specimen collection
can lead to erroneous results. It is therefore considered an important step of
good clinical laboratory practice and is referred to as "preanalytic control".
• Specimen collection can be done at the patient's bedside, in the laboratory or
in the field.
• Trained manpower/phlebotomist should be employed for specimen collection.
Other staff such as doctors, nurses and others who are involved in specimen
collection should also be trained periodically.
• Laboratory should have a "primary specimen collection manual", containing
information on patient preparation before specimen collection (if any), exact
methodology of specimen collection, labelling, handling, transportation and
storage of the specimens. In addition, the laboratory should provide adequate
and appropriate information/instructions to patients wherever necessary. All
preanalytical factors that may influence the test results should be identified.
The manual should include guidelines on specimen collection including
preservation for histopathological examination. These manuals should be
available for reference and should be used for training of staff engaged in
specimen collection.
• Specimen should be secured properly so that there is no leakage, spillage or
contamination. A Biohazard symbol should be used on the containers during
transportation. Appropriate specimen transportation kit (such as use of dry
ice, etc.) to be used wherever required. Specimen should be sent to the
laboratory along with the requisition form.
9.0 REQUISITION FORM
• The requisition form should be completed by the doctor requesting the tests
and sent along with the specimen/patient to the laboratory.
• It should contain the patient's identity, age, location, date of specimen collection
and the investigations requested. The referring doctor should be encouraged
to mention the provisional or working diagnosis and relevant clinical and
treatment history in the space provided (Annexure 2).
8 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
10.0 ACCESSION LIST
• Accession list is a record of all the specimens received by the laboratory for
analysis and is prepared by the laboratory at the time of specimen receipt
(Annexure 3).
• It records the patient's identity including name, age, sex, location in the hospital/
medical facility, name of referring physician, investigations requested, date
and time of receipt of specimen and condition of the specimen at receipt. The
laboratory assigns a unique laboratory number to register each specimen
received, which can be used to trace the specimen in the laboratory. The test
results and remarks if any are also entered in the accession list.
• In laboratories handling a very large number of specimens, the accession list
may be computer generated and the condition of specimen at receipt may not
be recorded unless it has been rejected.
11.0 WORKSHEET
• Worksheet is essentially a form provided to the analyst along with the specimen
(Annexure 4). The following details should be recorded on the worksheet:
Ø Date of analysis
Ø Condition of the specimen before starting analysis (should be entered in
the laboratory notes)
Ø Findings and result
Ø Name and signature of the analyst (In case of electronically generated and
maintained worksheets, appropriate control, validation and access
procedures should be built in the system)
• Laboratory number assigned to the specimen should be mentioned in the
worksheet before sending the specimen to the analyst.
• The specimen should be analyzed according to the plan mentioned in the
SOP. Any deviations from the analysis plan should be mentioned giving reasons.
Wherever applicable the laboratories can use requisition form cum worksheet
(Annexure 5) instead of two separate forms. However, laboratories using
electronic transmission of patients' details and test results may not require
individual worksheets.
INDIAN COUNCIL OF MEDICAL RESEARCH 9Guidelines for Good Clinical Laboratory Practices (GCLP)
12.0 REPORTING TEST RESULTS
• Test results approved and signed by the designated authority should be made
available to authorized person(s) only.
• Results should be reported clearly, without any errors, specifying measurement
procedure where appropriate and units of measurement as recommended by
professional societies such as International Council for Standardization in
Haematology, International Society of Haematology & International Federation
of Clinical Chemistry and Laboratory Medicine. A format for reporting results is
given in Annexure 6.
13.0 SPECIMEN REJECTION RECORD
• Laboratories should maintain a record of specimens which were rejected prior
to analysis. Rejection statistics (eg. number of hemolyzed specimen etc.)
along with reason for rejection and person responsible for rejection should be
maintained (Annexure 7).
• Specimen rejection statistics can be used by laboratories to identify the need
and areas for staff training. For example, if specimen contamination is detected,
the containers should be checked for sterility prior to collection as well as
specimen handling procedure. This information should be shared with the
medical, nursing and other staff engaged in specimen collection and
transportation.
14.0 DATA MANAGEMENT
• Laboratory data management includes recording details of the patient, findings
of analysis, reporting of results and archiving the data for future reference.
Recording data allows smooth functioning of the internal quality control
measures, internal audit and external quality assessment. From the point of
view of management, absence of record implies that the work was never
done.
• The format of recording and reporting results should be described in the
Standard Operating Procedures (SOPs).
• Data entry should begin as soon as registration number is assigned to the
specimen. Further entries should be made in the accession list and worksheet.
The final report should be recorded after approval/signature of the designated
authority.
• All auto analyzers should be connected with printer and uninterrupted power
supply (UPS). If printing option is not available or semi auto analyzers are
10 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
used, laboratory should maintain manual raw test data counter-checked by
two persons.
• The laboratory should maintain raw test data preferably for one month in non-
editable format or signed printed copy.
• Procedure for adequate data protection and security including data editing
and deleting should be developed and maintained by the laboratory.
Authorization for amendment procedure should be specified in the SOP. The
laboratory should also record reason for editing or deleting data.
• Facilities sending reports electronically should include electronic signature of
the authorized signatory. Laboratories should be able to provide critical
information required by a physician on telephone eg. frozen section biopsy
report is required while operating a patient with suspicion of cancer or growth
of a particular organism in culture can aid in early diagnosis and treatment.
15.0 STANDARD OPERATING PROCEDURE (SOP)
• SOP is a document, which contains detailed, written instructions describing
the stepwise process and technique of performing a test or procedure in the
laboratory.
• SOP helps to ensure uniformity, consistency and control over the processes
carried out. It ensures that the procedures are done in exactly the same way
each time irrespective of the operator.
• SOP should contain information on who can perform the test, their qualification
and training, how to carry out the test including pre-analytical, analytical and
post-analytical stages of test/procedure, laboratory conditions required for the
test/ procedure, routine care and maintenance of equipment, precautions and
safety instructions, trouble shooting measures, waste disposal and linkage
with reference laboratories.
• SOP should be simple and written in an easy to understand language.
• The procedure described in the SOP must be followed exactly by all staff
members to ensure high quality results.
• It should be titled along with version number, dated and signed by an authorized
person and updated regularly.
• It is important for the SOP document to be readily available in the working area
and is therefore also referred to as 'laboratory bench work manual'.
• SOPs are controlled documents and can be changed only with approval of
the laboratory quality manager and/or Head of the laboratory.
INDIAN COUNCIL OF MEDICAL RESEARCH 11Guidelines for Good Clinical Laboratory Practices (GCLP)
15.1 Format of SOP
The header of SOP should display the following information on all pages:
• Title of SOP and Document number
• Version number with dates of revision
• Issue number and date of issue of the document
• Page number/Number of pages
15.2 The text of SOP for test procedure should contain information on:
• Name of test
• Author's name and approving authority
• Scope of test
• Principle of the test
• Equipment and materials required
• Detailed test procedure including type, quantity and condition of specimen
required; sample processing and preparation. Alternative procedure for test in
case of breakdown of equipment should also be stated.
• Documentation of results including calculations
• Limit of detection (Analytical sensitivity)
• Analytical Measurement Range (AMR)
• Reference range
• Clinical significance, Inference and limitation of the test
• Critical alert values
• References of test procedure
• Precautions & Safety
• Quality Control procedures
• Specimen preservation and storage before analysis and after analysis
• Data management
12 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
15.3 Types of SOP include:
• Staff appointment, training, evaluation
• Maintenance of laboratory conditions including work space, lighting, ventilation,
temperature regulation, noise control, designated eating and smoking area
• Cleaning, sterilization & disinfecting procedures
• Equipment care, operation, calibration, validation and maintenance of
equipment
• Data Management
• Precautions & Safety measures including treatment if required and appropriate
vaccination of staff
• Handling and disposal of waste including bio-wastes
• Documentation of laboratory's reference ranges (In the absence of laboratory's
own reference ranges, data generated officially for Indian subjects or failing
that reference range on the manufacturer's guidelines contained in the kit
brochure may be used).
• Internal quality control procedures including procedure for reporting abnormal
test results and corrective action procedure for quality control outliers
• Internal audit procedures
• Participation in external quality assessment programmes
16.0 SAFETY IN LABORATORIES
Personnel working in laboratories may be exposed to risks from various chemicals,
infectious materials, fire hazard, gas leak etc. The environment is also at risk of being
contaminated by hazardous materials used and wastes generated in the laboratory.
Safety in laboratories therefore includes protection of both the staff and the
environment from hazardous materials.
16.1 General Safety Measures
• Documentation of Laboratory Safety Policies and Procedures.
• All laboratory personnel should be aware about the laboratory safety policies
and procedures and follow these at all times.
INDIAN COUNCIL OF MEDICAL RESEARCH 13Guidelines for Good Clinical Laboratory Practices (GCLP)
• List of hazardous materials used in the laboratory should be prepared. All
hazardous materials should be accounted for on a continuous basis.
• Laboratory personnel should follow safe hygienic practices which include hand
washing, wearing protective clothing, gloves, eye protection etc.
• Eye wash facility should be available as "stand-alone" facility or attached to
sink. Portable, sealed, refillable bottles should also be available.
• Biohazard symbol should be used on all container/equipment containing
biohazardous material.
• Laboratories should ensure proper preservation and security of specimens.
• Destruction/disposal of hazardous material should be authorized, supervised
and handled according to standard procedures.
• Laboratory personnel should be thoroughly trained in managing fire, and non-
fire emergencies such as large spillage, gas leakage etc.
• Adequate fire extinguishers should be readily available in the laboratory
• Periodic checking of all safety equipment and accessories should be ensured.
• Accident/incident/injuries record of laboratory personnel should be maintained
and reported to the designated authority. The report should include description
of the event, factors contributing to the event and information on first aid or
other health care provided. This information can be analyzed periodically
towards effectively controlling and preventing future events. The records should
be checked periodically by the laboratory safety officer even in the absence of
fresh entries.
16.2 Biosafety Precautions
• Laboratory personnel are at risk of exposure to a variety of infectious agents
and need to observe special precautions for safe handling of pathogenic
organisms in the laboratories.
• The World Health Organization (WHO) has classified pathogenic organisms
into 4 risk groups - WHO Risk groups 1, 2, 3 and 4, based on the infectivity of
an organism to cause disease in an individual and/or community (higher risk
group indicates higher infectivity). Risk group classification takes into account
the pathogenicity of the organism, mode of transmission, host factors such
as immunity, hygiene etc., local availability of effective preventive and treatment
measures.
14 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
• Four levels of biosafety laboratories (BSL) - 1, 2, 3 and 4, have been designed
for handling biohazardous material. Usually higher level of biosafety is required
while carrying out procedures using higher risk group organisms. However,
certain procedures which generate high concentration of a low risk organism,
may also necessitate the use of higher level of biosafety eg. generation of
aerosols. Laboratory facilities such as equipment, containment facilities,
ventilation, design etc. should be planned according to the risk group of
organisms which the laboratory is handling and also the test procedures
adopted.
• The management should facilitate the setting up of biosafety precautions in
the laboratory by providing adequate manpower, resources, infrastructure and
policy. A biosecurity and/or biosafety officer should be overall in-charge of
biosecurity/biosafety in the laboratory.
• The laboratories should have their own biosafety manual written in consultation
with the head of the laboratory. Policies should outline the use of sharps,
disposal of bio-waste, reagents, sharps and other wastes generated in the
laboratory in accordance with Bio-Medical Waste (Management & Handling)
Rules, 1998 (amended in 2000).
• All personnel working in the laboratory should be aware of these biosafety
precautions and trained to follow them always.
• Laboratory staff should also realize that they may be inadvertently exposed to
organisms of higher risk groups and therefore must observe safety precautions
laid down by the laboratory at all times.
• It is desirable to train all staff in good microbiological techniques (GMT) wherever
applicable.
• Laboratory staff cleared for working in Level-3 and Level-4 laboratories should
be specially trained and their clearances updated at regular intervals (e.g.
annually).
16.3 Levels of Biosafety Laboratories (BSL)
• BSL 1 can handle biological materials with minimum biohazard to the
laboratory personnel and environment eg. laboratories at PHC level, side
laboratories in labour rooms or wards. It is considered a cold zone. Access to
the laboratory should be limited to laboratory personnel and the staff should
use personal protection such as gowns, gloves, eye protection eg. glasses,
footwear, use a separate area for hand washing, storing food, drinks, etc. The
laboratory work can be carried out on open bench tops and the surface should
INDIAN COUNCIL OF MEDICAL RESEARCH 15Guidelines for Good Clinical Laboratory Practices (GCLP)
be decontaminated as per the safety requirements, arthropod and rodent control
measures should be followed, mouth pipetting should be replaced with
mechanical procedure and techniques which minimize splashes and aerosol
formation.
• BSL 2 laboratories are equipped with facilities to handle biomaterial which
pose moderate hazard in the event of injury to skin or exposure to mucous
membrane or ingestion. It is also considered a cold zone. All diagnostic and
healthcare laboratories in public or private sector should have BSL-2 facilities.
In addition to BSL-1 precautions, a biohazard warning sign should be displayed
at the entrance. Special care should be exercised while handling sharps and
an autoclave should be available for decontamination. Biohazardous material
should be handled in class I or II biological safety cabinets (BSC) within the
laboratory. Mechanical circulation of air with inward flow is preferred. Chemical,
fire, electrical safety measures should be followed. Eyewash station should
be conveniently located. All laboratory personnel should undergo pre-
employment health check-up and a record of their illnesses and immunization
received should be available to the laboratory managers.
• BSL 3 laboratories are located in teaching and/or research institutions,
production and clinical testing facilities. They can handle pathogenic agents
which can cause potentially lethal disease when inhaled. They are
containment laboratories and are considered a warm or neutral zone. Access
to the laboratory should be determined by the laboratory in-charge. Higher
degrees of personal protection of the laboratory staff is needed including
respiratory protection in certain instances. The staff should undergo baseline
and periodic serum testing for the agent being handled in the laboratory.
Laboratory design in addition to BSL-2 facilities should have a ducted exhaust
air ventilation system installed with negative airflow into the laboratory. Heating,
ventilation, air-conditioning (HVAC) control systems may be installed to avoid
positive pressure in the laboratory. High-efficiency particulate air (HEPA)
filtration should be used to re-circulate air into the laboratory. Handling of
biohazardous material should be done in BSC class I, II or III. Laboratory staff
should be trained to work in BSL-3 laboratories.
• BSL 4 laboratories or maximum containment laboratories are suitable for
handling dangerous and exotic agents with high risk of life threatening
disease associated with aerosol transmission. These laboratories should be
located in isolated areas. All biosafety precautions for BSL-3 laboratories should
be followed with additional safety practices including complete change of
clothing and shoes prior to entering and exiting from the laboratory. No
individual should work alone: two-person rule should be followed. Staff
16 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
should be trained to handle personnel injury or illness. All work should be
conducted in class III BSC or class II BSC with personal one-piece positive
pressure suits fitted with ventilatory support. Ventilation system should be non
re-circulating with unidirectional airflow from the area of least hazard to area(s)
of greatest potential hazard. HVAC control systems should be installed to
monitor airflow in the supply and exhaust systems. The facilities should be
negatively pressurized to prevent contamination if airflow system fails. High
Security Animal Disease laboratory (HSADL) is India's only BSL-4 laboratory
at Bhopal. It conducts research on all kinds of zoonotic diseases and emerging
infectious disease threats.
17.0 ETHICAL CONSIDERATIONS
Personnel working in clinical and/or research laboratories or engaged in biomedical
sciences or research should be aware of their ethical responsibilities and comply with
the ethical code of conduct which are governed by the following principles :
17.1 Principle Of Non-Maleficence, whereby it is ensured that activities, discoveries
or knowledge of personnel engaged in biomedical sciences 'do no harm' by -
i) refraining to engage in any activity or research that is intended or likely to
cause harm to plants, animals, humans or environment.
ii) refraining from contributing to the development, production or acquisition of
microbial or other biological agents or toxins, whatever their origin or method
of production, of types and/or in quantities that have no justification for
prophylactic, protective, therapeutic, or other peaceful purposes.
17.2 Principle Of Beneficence, whereby it is ensured that legitimate benefits are
being sought and that they out-weigh the risks and harms. The personnel should work
for the ethical and beneficial advancement, development and use of scientific
knowledge.
17.3 Principle Of Institutional Arrangement, whereby reasonable care is taken to
ensure that all procedures are required to be complied and all institutional arrangements
are required to be made to assure bio-safety and security. Access is allowed to
biological and other chemical agents that could cause harm, only to bonafide scientists
in a transparent manner who, there are reasonable grounds to believe, will not misuse
them. Appropriate committees to oversee the activities to be put in place.
17.4 Principle Of Risk Minimization, whereby due care and caution is taken to
provide all bio-safety precautions and restrict the dissemination of dual use of
information and knowledge where there are reasonable grounds to believe that there
are serious risks that information or knowledge could be readily misused to inflict
INDIAN COUNCIL OF MEDICAL RESEARCH 17Guidelines for Good Clinical Laboratory Practices (GCLP)
serious harm. Bring to the attention of the appropriate persons/authorities, activities
including unethical research, that there are reasonable grounds to believe are likely to
contribute to harm.
17.5 Principle Of Ethical Review, whereby research activities are subjected to ethics
and safety reviews and monitoring through appropriately constituted committees to
establish their ethical acceptability. If human or animal participants are involved, to
ensure that such involvement is ethical and essential for carrying out highly important
research by following the relevant national and international guidelines.
17.6 Principle Of Transmission Of Ethical Values, whereby (the duties and
obligations embodied in this code) the ethical principles upon which it is based are
transmitted faithfully to all who are, or may become, engaged in the conduct of
biomedical activities or research.
17.7 Principle Of Voluntariness, whereby researchers are fully apprised of the
research and the impact and risk of such research, and whereby scientists retain the
right to abstain from further participation in research that they consider ethically or
morally objectionable.
17.8 Principle Of Compliance, whereby personnel engaged in biomedical activities
and research abide by laws and regulations that apply to the conduct of science,
duties, and obligations embodied in this code, and disseminate the same to all
concerned.
18.0 QUALITY ASSURANCE
Quality Assurance (QA) is the total process whereby the quality of laboratory reports
can be guaranteed. Incorrect Laboratory results may be due to errors occuring during
specimen collection (pre-analytical stage), testing (analytical stage) and/or while
reporting and interpreting (post-analytical stage) test results. Whereas, Internal Quality
Control (IQC) refers to the process of minimizing analytical errors, QA encompasses
procedures adopted for minimizing errors that may occur at any stage. Provision of
precise and accurate laboratory results optimize medical management. Inappropriate
test selection, unnecessary investigations and incorrect test results not only have
serious health implications but are also a financial burden to the individual and
community. Reports from a laboratory with a high level of QA will help the physician to
arrive rapidly at a correct diagnosis. To provide QA, all laboratories must have a Quality
Assurance Programme (QAP) in place.
19.0 QUALITY ASSURANCE PROGRAMME (QAP)
• QAP is a managerial process of maintaining high standards of performance
and of improving standards where necessary. The concept is best illustrated
18 INDIAN COUNCIL OF MEDICAL RESEARCHGuidelines for Good Clinical Laboratory Practices (GCLP)
by Deming's cycle of Planning (P), Doing (D), Checking (C), and Acting (A). If
any of the four components of the cycle lag behind then the quality declines.
While planning a QAP it is important to put effort at each step to prevent,
detect and correct errors.
• Quality Manager or designee or competent authorized person should review
the quality control data and maintain record of evaluation.
• The two important tools toward maintaining laboratory quality are
Ø Internal Quality Control (IQC) - for detection and minimization of immediate
errors
Ø External Quality Assessment (EQA) - for monitoring long term precision
and accuracy of results.
• The laboratory should treat IQC/EQA samples and patients' specimens
alike and use same procedures for analysis.
20.0 INTERNAL QUALITY CONTROL
20.1 Practice of IQC
This includes the following:
• Recognition of errors which arise within the laboratory during analytical stage
(testing).
Ø Taking steps to minimize errors.
Ø Equipment & method calibration, method validation (Annexure 8).
• Laboratories should perform IQC
Ø Every day on tests run daily
Ø Every time the tests are run in case of infrequently used tests.
• Quality control checks should be employed for both quantitative and qualitative tests.
20.2 IQC for Quantitative Tests
• Levy Jennings's (LJ) chart should be used to plot daily QC values (Annexure 9).
It indicates the changes in trends and shifts of the laboratory performance.
Westgard rules should be used to interpret daily QC values. The level of QC
applied in the laboratory varies according to the number of specimens analyzed
INDIAN COUNCIL OF MEDICAL RESEARCH 19
